Gleave M - Search Results

1

The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.

Martin MJ, Melnyk N, Pollard M, Bowden M, Leong H, Podor TJ, Gleave M, Sorensen PH. Martin MJ, et al. Among authors: gleave m. Mol Cell Biol. 2006 Mar;26(5):1754-69. doi: 10.1128/MCB.26.5.1754-1769.2006. Mol Cell Biol. 2006. PMID: 16478996 Free PMC article.

2

Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.

Miyake H, Nelson C, Rennie PS, Gleave ME. Miyake H, et al. Among authors: gleave me. Endocrinology. 2000 Jun;141(6):2257-65. doi: 10.1210/endo.141.6.7520. Endocrinology. 2000. PMID: 10830316

3

Effect of time of castration and tumour volume on time to androgen-independent recurrence in Shionogi tumours.

So AI, Bowden M, Gleave M. So AI, et al. Among authors: gleave m. BJU Int. 2004 Apr;93(6):845-50. doi: 10.1111/j.1464-410X.2003.04726.x. BJU Int. 2004. PMID: 15050003

4

Increased insulin-like growth factor I receptor expression and signaling are components of androgen-independent progression in a lineage-derived prostate cancer progression model.

Krueckl SL, Sikes RA, Edlund NM, Bell RH, Hurtado-Coll A, Fazli L, Gleave ME, Cox ME. Krueckl SL, et al. Cancer Res. 2004 Dec 1;64(23):8620-9. doi: 10.1158/0008-5472.CAN-04-2446. Cancer Res. 2004. PMID: 15574769

5

Hypoxia in the androgen-dependent Shionogi model for prostate cancer at three stages.

Skov K, Adomat H, Bowden M, Dragowska W, Gleave M, Koch CJ, Woo J, Yapp DT. Skov K, et al. Among authors: gleave m. Radiat Res. 2004 Nov;162(5):547-53. doi: 10.1667/rr3254. Radiat Res. 2004. PMID: 15624309

6

Inhibition of the phosphatidylinositol 3'-kinase pathway promotes autocrine Fas-induced death of phosphatase and tensin homologue-deficient prostate cancer cells.

Bertram J, Peacock JW, Tan C, Mui AL, Chung SW, Gleave ME, Dedhar S, Cox ME, Ong CJ. Bertram J, et al. Cancer Res. 2006 May 1;66(9):4781-8. doi: 10.1158/0008-5472.CAN-05-3173. Cancer Res. 2006. PMID: 16651432

7

Insulin receptor expression by human prostate cancers.

Cox ME, Gleave ME, Zakikhani M, Bell RH, Piura E, Vickers E, Cunningham M, Larsson O, Fazli L, Pollak M. Cox ME, et al. Among authors: gleave me. Prostate. 2009 Jan 1;69(1):33-40. doi: 10.1002/pros.20852. Prostate. 2009. PMID: 18785179

8

PTEN loss promotes mitochondrially dependent type II Fas-induced apoptosis via PEA-15.

Peacock JW, Palmer J, Fink D, Ip S, Pietras EM, Mui AL, Chung SW, Gleave ME, Cox ME, Parsons R, Peter ME, Ong CJ. Peacock JW, et al. Among authors: gleave me. Mol Cell Biol. 2009 Mar;29(5):1222-34. doi: 10.1128/MCB.01660-08. Epub 2008 Dec 22. Mol Cell Biol. 2009. PMID: 19103758 Free PMC article.

9

Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.

Furukawa J, Wraight CJ, Freier SM, Peralta E, Atley LM, Monia BP, Gleave ME, Cox ME. Furukawa J, et al. Among authors: gleave me. Prostate. 2010 Feb 1;70(2):206-18. doi: 10.1002/pros.21054. Prostate. 2010. PMID: 19790231

10

Clusterin is a critical downstream mediator of stress-induced YB-1 transactivation in prostate cancer.

Shiota M, Zoubeidi A, Kumano M, Beraldi E, Naito S, Nelson CC, Sorensen PH, Gleave ME. Shiota M, et al. Among authors: gleave me. Mol Cancer Res. 2011 Dec;9(12):1755-66. doi: 10.1158/1541-7786.MCR-11-0379. Epub 2011 Oct 10. Mol Cancer Res. 2011. PMID: 21987172

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

687 results

Search Page

Filters